Abstract:Background. Hepatocellular carcinoma (HCC) is one of the deadliest tumors. The majority of HCC is detected in the late stage, and the clinical results for HCC patients are poor. There is an urgent need to discover early diagnostic biomarkers and potential therapeutic targets for HCC.Methods. The GSE87630 and GSE112790 datasets from the Gene Expression Omnibus (GEO) database were downloaded to analyze the differentially expressed genes (DEGs) between HCC and normal tissues. R packages were used for Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses of the DEGs. A Search Tool for Retrieval of Interacting Genes (STRING) database was used to develop a protein-protein interaction (PPI) network, and also cytoHubba, Molecular Complex Detection (MCODE), EMBL-EBI, CCLE, Gene Expression Profiling Interactive Analysis (GEPIA), and Oncomine analyses were performed to identify hub genes. Gene expression was verified with a third GEO dataset, GSE25097. The Cancer Genome Atlas (TCGA) database was used to explore the correlations between the hub genes and clinical indexes of HCC patients. The functions of the hub genes were enriched by gene set enrichment analysis (GSEA), and the biological significance of the hub genes was explored by real-time polymerase chain reaction (qRT-PCR), western blot, immunofluorescence, CCK-8, colony formation, Transwell and flow cytometry assays with loss-of-function experiments in vitro.Results. Centromere protein N (CENPN) was screened as a hub gene affecting HCC tumorigenesis. Evaluation by Cox regression showed that a high level of CENPN expression was an independent danger variable for poor prognosis of HCC. GSEA showed that high CENPN expression was linked to the following pathways: liver cancer subclass proliferation, cell cycle, p53 signaling pathway, Rb1 pathway, positive regulation of cell cycle G1/S phase transition, and DNA damage response signal transduction by p53 class moderators. Further cell experiments showed that knocking down CENPN expression decreased the proliferation and colony-forming abilities of HepG2 and Huh7 cells as well as Ki67 expression in these cell lines. The cell cycle was arrested in G1 phase, which is consistent with previous experiments on CENPN downregulation., but neither migration nor invasion were significantly affected. Western blot results revealed that the expression of p53, p27, p21, CDK4, cyclin D1, CDK2, cyclin E, pRb, E2F1 and c-myc decreased after CENPN knockdown, but there was no significant change in total Rb levels. In addition, CENPN-knockdown cells subjected to irradiation showed significantly enhanced of gamma-H2AX expression and reduced colony formation.Conclusion. CENPN functions as an oncogene in HCC and may be a therapeutic target and promising prognostic marker for HCC.

CENPA knockdown restrains cell progression and tumor growth in breast cancer by reducing PLA2R1 promoter methylation and modulating PLA2R1/HHEX axis

Single-Cell and Bulk RNA Sequencing Analysis Reveals CENPA As a Potential Biomarker and Therapeutic Target in Cancers

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway

Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration

Centromere Protein F is Identified As a Novel Therapeutic Target by Genomics Profile and Contributing to the Progression of Pancreatic Cancer.

CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1

CPNE1 Predicts Poor Prognosis and Promotes Tumorigenesis and Radioresistance Via the AKT Singling Pathway in Triple-Negative Breast Cancer

Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway.

CENPE Promotes Lung Adenocarcinoma Proliferation and is Directly Regulated by FOXM1

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker

Short Hairpin RNA-mediated Down-Regulation of CENP-A Attenuates the Aggressive Phenotype of Lung Adenocarcinoma Cells

The Centromere-Associated Protein CENPU Promotes Cell Proliferation, Migration, and Invasiveness in Lung Adenocarcinoma.

CENPH Overexpression Promotes the Progression, Cisplatin Resistance, and Poor Prognosis of Lung Adenocarcinoma Via the AKT and ERK/P38 Pathways.

Downregulation of CENPK Suppresses Lung Adenocarcinoma by Regulating EMT

Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways

Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway

m6A-modified cenRNA stabilizes CENPA to ensure centromere integrity in cancer cells

Centromere Protein N May Be A Novel Malignant Prognostic Biomarker For Hepatocellular Carcinoma

CENPO Expression Regulates Gastric Cancer Cell Proliferation and is Associated with Poor Patient Prognosis